Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up
Titel:
Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up
Auteur:
Yenerel, Mustafa N. Sicre de Fontbrune, Flore Piatek, Caroline Sahin, Fahri Füreder, Wolfgang Ortiz, Stephan Ogawa, Masayo Ozol-Godfrey, Ayca Sierra, J. Rafael Szer, Jeff